VSee Health, Inc. is a technology company that specializes in providing telehealth solutions aimed at enhancing patient care through innovative communication tools. Their platform enables healthcare providers to conduct virtual consultations, facilitating remote access to medical services while improving efficiency and patient engagement. VSee's offerings include video conferencing, secure messaging, and remote patient monitoring, catering to a diverse range of healthcare settings, from hospitals to outpatient clinics. The company is dedicated to advancing healthcare delivery and making quality medical services more accessible to patients. Read More
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Fourth paragraph, first sentence of release dated July 14, 2025 should read: Dr. Ramon Lizardo MD, CEO of Tele911 (instead of Dr. Ramone Lizardo, MD, CEO of Tele911).
Imagine a world where stroke recovery happens from the comfort of home. A world where AI-powered nursing robots reduce hospital costs, and maternal care reaches the most remote corners of the world with just a mobile signal. That’s not a futuristic dream—it’s the reality VSee Health (Nasdaq: VSEE) is building today.
VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions.
VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq’s listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the “SEC”).
VSee Health (Nasdaq: VSEE ) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSEE accelerates telehealth adoption by enabling seamless, scalable and secure digital health solutions across hospitals, governments, and enterprise organizations.
VSee Health, Inc. (Nasdaq: VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay.
VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”), the Company is not in compliance with Nasdaq’s listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the “SEC”).
VSee Health, Inc. (NASDAQ: VSEE), a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform, has completed development of its Telenursing Robotics solution—an AI-driven platform designed to automate routine nursing tasks and reduce labor costs. With nursing expenses representing approximately 60% of hospital operating budgets, this innovation directly targets one of the most pressing cost challenges in healthcare. Initial modeling suggests hospitals deploying VSee’s solution could reduce nursing-related expenses by 3–5%, while also enhancing patient throughput and experience.
VSee Health (Nasdaq: VSEE ) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSEE accelerates telehealth adoption by enabling seamless, scalable and secure digital health solutions across hospitals, governments, and enterprise organizations.
VSee Health (NASDAQ: VSEE), a rapidly growing leader in AI-powered telehealth, is redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by more than 1,000 clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health accelerates telehealth adoption by enabling seamless, scalable and secure digital health solutions across hospitals, governments, and enterprise organizations.
VSee Health, Inc. (Nasdaq: VSEE), a leader in customizable digital health platforms and telehealth workflow solutions, announces securing a contract totalling $444K with one of the largest counties in the U.S., to deploy a white-label telehealth and data analytics platform for mental and behavioral health services. This strategic win highlights VSee's growing government sector presence and its ability to deliver scalable healthcare technology to underserved populations.
VSee Health (Nasdaq: VSEE ) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSEE accelerates telehealth adoption by enabling seamless, scalable, and secure digital health solutions across hospitals, governments, and enterprise organizations.
VSee Health (NASDAQ: VSEE), a leading provider of telehealth solutions, partnered with LanguageLine Solutions, the world’s leading interpretation service to enable instant, one-touch interpreter access across 240+ languages, further strengthening VSee Health’s position as a leading telehealth solutions provider for hospitals, enterprises, and government healthcare systems.
VSee Health, Inc. (Nasdaq: VSEE), the leader in AI digital health workflows, telehealth, and electronic health record (EHR) solutions, signed a $560K contract with one of the largest oncology networks in the U.S. to deploy a secure, compliant telehealth platform and virtual command center for remote patient and staff coordination. This contract underscores VSee’s ability to deliver enterprise-grade digital health infrastructure that is scalable, secure, and highly customizable, positioning the company as a disruptive force in the expanding digital health market.
